ArticlePediatric radiology2026
Automated fetal magnetic resonance imaging lung segmentation for rapid lung volume estimation across diverse pulmonary hypoplasia phenotypes.
Article in Pediatric radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundFetal magnetic resonance imaging (MRI)-derived lung volume measurements are used for prenatal risk stratification in conditions associated with pulmonary hypoplasia, but manual segmentation is time-intensive.
objectiveTo evaluate whether automated fetal MRI lung segmentation enables rapid and reliable volumetric assessment across diverse pulmonary hypoplasia phenotypes. MATERIALS AND
methodsIn this retrospective study, fetal MRI examinations performed from 2016 to 2025 with expert-adjudicated lung segmentations obtained during clinical care were used for model development and testing. Automated segmentation pipelines were developed for total lung volume (TLV) and percent predicted lung volume (PPLV). Performance was assessed using Dice similarity coefficient (DSC), absolute percentage error (APE), Bland-Altman analysis, intraclass correlation coefficient (ICC), case-level risk-category agreement, and inference time. Lowest-performing TLV outputs were adjudicated by a fetal radiologist to simulate a human-in-the-loop workflow.
resultsThe final dataset included 906 fetal MRI examinations with complete and recoverable lung segmentations, acquired at a mean gestational age of 27.1 weeks, range 16-38 weeks. Automated TLV estimation showed excellent agreement with manual volumetry (ICC, 0.955; mean DSC, 0.81±0.10; median APE 11.1%). Automated PPLV estimation showed lower performance (ICC, 0.727; mean DSC, 0.76±0.12; median APE 14.5%). Mean inference time was 4 s per examination. Correction of the 25 lowest-performing TLV outputs required 3.1 min per case.
conclusionAutomated fetal MRI lung segmentation enables rapid TLV estimation across diverse pulmonary hypoplasia phenotypes and may improve clinical workflow efficiency while preserving expert oversight for challenging cases.
Indexed as
Identifiers
42700234What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.